Abstract
A considerable number of patients undergoing allogeneic hematopoietic SCT (HSCT) develop post-transplant complications requiring intensive care unit (ICU) treatment. Whereas the indications and the outcome of ICU admission are well known, the risk factors leading to ICU admission are less well understood. We performed a retrospective single-center study on 250 consecutive HSCT patients analyzing the indications, risk factors and outcome of ICU admission. Of these 250 patients, 33 (13%) were admitted to the ICU. The most common indications for admission to the ICU were pulmonary complications (11, 33%), sepsis (8, 24%), neurological disorders (6, 18%) and cardiovascular problems (2, 6%). Acute GvHD and HLA mismatch were the only significant risk factors for ICU admission in multivariate analysis. Among patients admitted to the ICU, the number of organ failures correlated negatively with survival. Twenty-one (64%) patients died during the ICU stay and the 6-month mortality was 85% (27 out of 33). SAPS II score underestimated the mortality rate. In conclusion, acute GvHD and HLA mismatch were identified as risk factors for ICU admission following allogeneic HSCT. Both, short- and long-term survival of patients admitted to the ICU remains dismal and depends on the number of organ failures.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Copelan EA . Hematopoietic stem-cell transplantation. N Engl J Med 2006; 354: 1813–1826.
Afessa B, Azoulay E . Critical care of the hematopoietic stem cell transplant recipient. Crit Care Clin 2010; 26: 133–150.
Naeem N, Reed M, Creger R, Youngner S, Lazarus H . Transfer of the hematopoietic stem cell transplant patient to the intensive care unit: does it really matter? Bone Marrow Transplant 2006; 37: 119–133.
Pène F, Aubron C, Azoulay E, Blot F, Thiéry G, Raynard B et al. Outcome of critically ill allogeneic hematopoietic stem-cell transplantation recipients: a reappraisal of indications for organ failure supports. J Clin Oncol 2006; 24: 643–649.
Gilli K, Remberger M, Hjelmqvist H, Ringden O, Mattsson J . Sequential organ failure assessment predicts the outcome of SCT recipients admitted to intensive care unit. Bone. Marrow Transplant 2010; 45: 682–688.
Hassan NE, Mageed AS, Sanfilippo DJ, Reischman D, Duffner UA, Rajasekaran S . Risk factors associated with pediatric intensive care unit admission and mortality after pediatric stem cell transplant: possible role of renal involvement. World J Pediatr 2013; 9: 140–145.
Ajani* S, Litzow M, Hogan W, Peters S, Afessa B . RIsk factors for icu admission in hematopoietic stem cell transplantation (HSCT) recipients. CHEST J 2012; 142: 307A (abstract).
Groeger JS, White P, Nierman DM, Glassman J, Shi W, Horak D et al. Outcome for cancer patients requiring mechanical ventilation. J Clin Oncol 1999; 17: 991–997.
Price KJ, Thall PF, Kish SK, Shannon VR, Andersson BS . Prognostic indicators for blood and marrow transplant patients admitted to an intensive care unit. Am J Respir Crit Care Med 1998; 158: 876–884.
Faber-Langendoen K, Caplan A, McGlave P . Survival of adult bone marrow transplant patients receiving mechanical ventilation: a case for restricted use. Bone. Marrow Transplant 1993; 12: 501–507.
Ewig S, Torres A, Riquelme R, El-Ebiary M, Rovira M, Carreras E et al. Pulmonary complications in patients with haematological malignancies treated at a respiratory ICU. Eur Respir J 1998; 12: 116–122.
Soubani A, Kseibi E, Bander J, Klein J, Khanchandani G, Ahmed H et al. Outcome and prognostic factors of hematopoietic stem cell transplantation recipients admitted to a medical ICU. Chest 2004; 126: 1604–1611.
Kew A, Couban S, Patrick W, Thompson K, White D . Outcome of hematopoietic stem cell transplant recipients admitted to the intensive care unit. Biol Blood Marrow Transplant 2006; 12: 301–305.
Silfvast T, Pettilä V, Ihalainen A, Elonen E . Multiple organ failure and outcome of critically ill patients with haematological malignancy. Acta Anaesthesiol Scand 2003; 47: 301–306.
Bird GT, Farquhar-Smith P, Wigmore T, Potter M, Gruber PC . Outcomes and prognostic factors in patients with haematological malignancy admitted to a specialist cancer intensive care unit: a 5yr study. Br J Anaesth 2012; 108: 452–459.
Hampshire P, Welch C, McCrossan L, Francis K, Harrison D . Admission factors associated with hospital mortality in patients with haematological malignancy admitted to UK adult, general critical care units: a secondary analysis of the ICNARC Case Mix Programme Database. Crit Care 2009; 13: R137.
Afessa B, Tefferi A, Hoagland HC, Letendre L, Peters SG . Outcome of recipients of bone marrow transplants who require intensive-care unit support. Mayo Clin Proc 1992; 67: 117–122.
Jackson S, Tweeddale M, Barnett M, Spinelli J, Sutherland H, Reece D et al. Admission of bone marrow transplant recipients to the intensive care unit: outcome, survival and prognostic factors. Bone Marrow Transplant 1998; 21: 697–704.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no conflict of interest.
Rights and permissions
About this article
Cite this article
Benz, R., Schanz, U., Maggiorini, M. et al. Risk factors for ICU admission and ICU survival after allogeneic hematopoietic SCT. Bone Marrow Transplant 49, 62–65 (2014). https://doi.org/10.1038/bmt.2013.141
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/bmt.2013.141
Keywords
This article is cited by
-
AKI treated with kidney replacement therapy in critically Ill allogeneic hematopoietic stem cell transplant recipients
Bone Marrow Transplantation (2024)
-
Temporal trends in critical care utilization and outcomes in allogeneic hematopoietic stem cell transplant recipients
Annals of Hematology (2024)
-
Impact of pre-transplant individual comorbidities on risk of ICU admission and survival outcomes following allogeneic hematopoietic stem cell transplantation
Bone Marrow Transplantation (2023)
-
High-flow nasal cannula oxygen in patients with haematological malignancy: a retrospective observational study
Annals of Hematology (2022)
-
Outcome of allogeneic hematopoietic stem cell transplant recipients admitted to the intensive care unit with a focus on haploidentical graft and sequential conditioning regimen: results of a retrospective study
Annals of Hematology (2021)